A Study of Intravenous MabThera/Rituxan in Pediatric Patients With Severe Granulomatosis With Polyangiitis (Wegener's) or Microscopic Polyangiitis

Condition:   Wegener's Granulomatosis, Microscopic PolyangiitisIntervention:   Drug: rituximab [MabThera/Rituxan]Sponsor:   Hoffmann-La RocheRecruiting - verified January 2015
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials